Pune, March 10, 2023 (GLOBE NEWSWIRE) -- Warfarin market report is knowledge and experience shared by industry experts to take correct decisions for manufacturers, new entrants, and industry chain-related companies. The report includes a worldwide study with top players in the market, growth in the near future, revenue and share in the market, challenges, and opportunities in the past and future.
Warfarin market report offers segmentation by product type, application, regional breakup, market size, volume, and value. This report has delivered the key development plans, such as innovative trends and expansions, strengthening of product portfolio, mergers and acquisitions, collaborations, new product invention, and geographical development, undertaken by these participants to maintain their presence.
Get a Sample Copy of the Report at - https://www.absolutereports.com/enquiry/request-sample/22705457
Warfarin is a kind of coumarin anticoagulant, which has the effect of anti-vitamin K in the body. It can inhibit the synthesis of coagulation factors Ⅱ, Ⅶ, Ⅸ and Ⅹ involved in vitamin K in the liver. There is no resistance to the existing coagulation factors Ⅱ, Ⅶ, Ⅸ, Ⅹ in the blood. Therefore, it cannot be used as an in vitro anticoagulant. In vivo anticoagulation must be effective only after the active coagulation factors are consumed. Warfarin market finds that the global Warfarin market reached a value of USD 540.21 million in 2022. It’s expected that the market will achieve USD 566.73 million by 2028, exhibiting a CAGR of 0.8% during the forecast period.
Geographic Segmentation: -
- North America
- Europe
- Asia-Pacific
- South America
- The Middle East and Africa
From 2022-2027, North America is estimated to witness robust growth prospects
Key players in the global market include: -
- Upsher-Smith Laboratories (Sawai Pharmaceutical Co.,Ltd)
- Qilu Pharmaceutical
- Ipca Laboratories
- Sine Pharma (Shanghai Pharma)
- Cipla
- Sun Pharmaceutical Industries
- Bristol Myers Squibb
- Bristol Laboratories
- Amneal Pharmaceuticals
- Orion Corporation Orion Pharma
- TEVA
- Zydus Cadila
Sun Pharmaceutical Industries is one of the major players operating in the Warfarin market, holding a share of 21.86% in 2020.
Inquire or Share Your Questions If Any Before Purchasing This Report – https://www.absolutereports.com/enquiry/pre-order-enquiry/22705457
Strength -
The main indication for warfarin is to prevent and treat venous thromboembolism and its expansion, such as pulmonary embolism. Warfarin can also be used to prevent non-rheumatic atrial fibrillation and risk factors, especially previous thromboembolism (transient ischemic attack or ischemic stroke), diabetes and hypertension.
Opportunity -
One of the most common indications for anticoagulation is to reduce the risk of stroke associated with non-rheumatic atrial fibrillation, especially in the elderly. The prevalence of atrial fibrillation approximately doubles with age. A large number of stroke patients are diagnosed with non-rheumatic atrial fibrillation. As the population ages, stroke prevention of atrial fibrillation will continue to be an important management issue.
Threat -
Warfarin is contraindicated during pregnancy (especially during organ formation) (6-12 weeks). Due to the immature liver of the fetus, there is still a risk of fetal bleeding throughout the pregnancy. In Australia, warfarin is usually not taken at any stage of pregnancy.
Segmentation by Types: -
- 1mg/Tablet
- 2.5mg/Tablet
- 3mg/Tablet
- 5mg/Tablet
- Others
2.5mg/Tablet segment accounted for the largest share of market in 2021.
Segmentation by Applications: -
- Mechanical Heart Valves (MHV) Replacement
- Atrial Fibrillation (AF)
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Others
The market's largest segment by application is the segment Mechanical Heart Valves (MHV) Replacement, with a market share of 33.97% in 2021.
COVID-19 and Russia-Ukraine War Influence Analysis: -
The readers in the section will understand how the Warfarin market scenario changed across the globe during the pandemic, post-pandemic, and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production.
To Understand How COVID-19/ Russia-Ukraine War Influence Impact covered at – https://www.absolutereports.com/enquiry/request-covid19/22705457
Reasons to Buy This Report: -
- This report stays updated with novel technology integration, features, and the latest developments in the market
- This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Warfarin industry.
- This report helps stakeholders to gain insights into which regions to target globally
- This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Warfarin.
- This report helps stakeholders to identify some of the key players in the Warfarin market and understand their valuable contributions.
TOC of Warfarin Market Research Report: -
1. Market Definition and Statistical Scope
2. Research Findings and Conclusion
3 Key Companies’ Profile
4. Global Warfarin Market Segmented by Type
5 Global Warfarin Market Segmented by Downstream Industry
6 Warfarin Industry Chain Analysis
7. The Development and Dynamics of Warfarin Market
8 Global Warfarin Market Segmented by Geography
9 North America
10 Europe
11 Asia Pacific
12 Latin America
13 Middle East & Africa
15 Appendix
Purchase this Report (Price 3160 USD for a Single-User License) – https://www.absolutereports.com/checkout/22705457
About Absolute Reports: -
Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in-depth market research. We are one of the top report resellers in the market, dedicated to bringing you an ingenious concoction of data parameters.
From 2022-2027, North America is estimated to witness robust growth prospects
